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were given for the following events: Initial contact, peak knee ﬂexion
and toe-off. In addition knee and hip excursion (ROM) were calculated.
Moments were given as internal moments.
Results: Fifty-two patients, 33 women and 20 men, with a mean
age of 60.3 (range 39.9–80.6) years were included. Of these, 12 had
bilateral hip OA. Mean MJS in the affected hip joints was 2.01 (SD 1.14)
mm, and mean HHS score 78.3 (SD 8.0). There were no signiﬁcant
differences between the PE and the PE+ET group at baseline. Signiﬁcant
differences were established in gait characteristics between the affected
and unaffected hip joints at baseline, in that knee and hip excursion
(ROM) were decreased, and hip and knee extension moments at peak
knee ﬂexion were reduced in the affected joints (p < 0.05). There were no
signiﬁcant differences between the two intervention groups at follow-
up. However, a signiﬁcant improvement was found in knee extension
moment (p = 0.046) on the affected side, but not the unaffected, in both
groups.
Conclusions: Gait characteristics during the stance phase of gait were
signiﬁcantly altered in the affected joints already at the stage of hip OA
when patients have mild to moderate pain. There were no signiﬁcant
differences between the two intervention groups at follow-up.
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ELUSIVE ROLE FOR TOLL LIKE RECEPTOR 2 IN JOINT PATHOLOGY
DURING EXPERIMENTAL OSTEOARTHRITIS
A.B. Blom, P.L. van Lent, S. Abdollahi-Roodsaz, P. van der Kraan, W. van
den Berg. Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands
Purpose: There has been a huge interest in the involvement of Toll-
Like Receptors (TLR) in human and experimental arthritis. Several
endogenous ligands for TLR-2, like biglycan, hyaluronan or HMGB-1, are
present in osteoarthritic joints. However, the involvement of this receptor
in osteoarthritis (OA) has not been studied extensively. The present
study was performed to evaluate the role of TLR-2 in experimental OA
pathology.
Methods: Three different models for OA were used, collagenase
induced OA (CIOA), destabilization of the medial meniscus (DMM) and
spontaneous OA in IL-1ra−/− murine knee joints. CIOA was induced by 2
intra-articular injections of 1 Unit collagenase into murine knee joints.
Due to the instability that results from these injections, OA-like pathology
develops within 42 days. At day 42, knee joints are dissected and
processed for histological examination. DMM was induced by surgical
transsection of the ligament that stabilizes the medial meniscus, which
results in an OA-like phenotype within 56 days. OA-like changes in
the cartilage of 4 joint surfaces were scored using a modiﬁed Pritzker
score. Five sections of each joint were scored. The role of TLR2 was
studied by induction of CIOA and DMM OA in TLR2−/− mice (n =16) and
C57BL/6 controls (n = 15), and by backcrossing of TLR-2−/− mice to IL-1-
ra−/− mice. At different time points during OA development, synovial
tissue was isolated to study TLR-2 expression in the wild type (WT)
mice by Q-PCR.
Results: Synovial activation, indicated by thickening of the synovial lining
layer, was studied in the three OA models. During CIOA and to a lesser
extend in the IL-1ra−/− mice, synovial activation was clearly present
during the whole course of the disease. However, no synovial activation
was observed in the DMM model. At day 7 after induction of CIOA in
WT mice, synovial TLR-2 levels were upregulated up to 56 fold, probably
a reﬂection of cellular inﬂux at this time point. At day 21 TLR2 levels
were up 2-fold and 42 after induction, TLR-2 levels in the synovium
were down to levels found in naïve mice. In the DMM model, TLR-2 was
not regulated at any of these time points.During CIOA in TLR2−/− mice,
OA cartilage pathology increased from 10.0 in the wildtype controls to
15.5 (p < 0.02). Changes were observed in all surfaces, but were strongest
in the lateral compartment of the joint, both in the femur and tibia.
Incidence of severe cartilage damage was increased in the medial femur,
medial tibia, lateral femur and lateral tibia respectively from 13% to 44%,
from 27% to 69%, from 60% to 81% and from 53% to 81%. In knee joints of
IL-1ra−/− mice, damage was less severe compared to CIOA WT mice with
a mean score of 2.2 and showed an increase in the IL-1ra−/−/TLR2−/− up to
a score of 4.1. In contrast, cartilage pathology during DMM OA in TLR2−/−
was not changed in the medial compartment of the joints, compared
to WT mice, respectively 13.7 and 14.7. Severe cartilage damage did not
differ between WT and TLR2−/−, 30% and 40% respectively. In all models,
synovial activation in TLR-2−/− mice was comparable to the WT, indicating
no direct role for TLR-2 in synovial activation.
Conclusions: In contrast to our expectations, these studies indicate that
in TLR2 deﬁcient mice OA pathology is more severe in experimental OA
that involves synovial activation. This suggests a protective role for this
receptor in OA, in stead of the inducing roles that were anticipated. This
protective role was abolished in the absence of synovial activation, as
was found in the DMM model. The mechanisms via which TLR2 exerts
this effect remain unclear, although stimulation of TLR2 by endogenous
ligands such as biglycan, hyaluronan or HMGB-1 has been shown to
induce IL-10, TGFb and HGF, which are protective mediators for OA.
Although further research is needed, these results indicate that during
OA the TLR-2 pathway protects cartilage from developing OA and that this
effect is mediated by the synovium. These ﬁndings may have important
implications for future therapies.
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SYNOVIAL FLUID FROM PATIENTS WITH OSTEOARTHRITIS AND
MENISCAL INJURY MODULATES THE RESPONSE OF FIBROBLAST-LIKE
SYNOVIOCYTES TO TLR-2 AND TLR-4 LIGANDS VIA SOLUBLE CD14
C.R. Scanzello1, A. Nair1, V. Kanda1, C. Bush-Joseph1, N. Verma1,
S. Chubinskaya1, K. Mikecz1, A-M. Malfait1, M.K. Crow2, G.T. Spear1,
A. Finnegan1. 1Rush Univ. Med. Ctr., Chicago, IL, USA; 2Hosp. for Special
Surgery, New York, NY, USA
Purpose: Synovial inﬂammation is detectable in osteoarthritis (OA)
patients as well as patients with meniscal injuries, and this synovitis is
associated with symptoms. Inﬂammation in OA is thought to be triggered
in part by products of tissue degradation via stimulation of innate
pattern-recognition receptors such as the Toll-like Receptors (TLRs).
Many endogenous ligands of Toll-like receptors have been described,
some of which are present in the OA and injured joint. We tested whether
a TLR-2 or TLR-4 stimulating factor could be detected in synovial ﬂuid
(SF) from early knee OA patients, and lead to inﬂammatory activation of
synoviocytes.
Methods: SF was obtained from patients with early OA undergoing
arthroscopic meniscal procedures. HEK293 cells transfected with either
TLR-4, or TLR-4 + MD2, or transfected with CD14 or TLR-2 + CD14
were used to screen SF for the ability to induce IL-8 production. Primary
cultures of ﬁbroblast-like synoviocytes (FLS) were established from post-
mortem tissue donors, and also stimulated with a TLR-4 stimulus (LPS),
a TLR-2 stimulus (Pam3Cysk4) SF alone, or SF in combination with LPS or
Pam3CysK4. Interleukin-8 (IL-8) in culture supernatants was measured
by ELISA. In blocking experiments, SF was pre-incubated with anti-CD14
(clone MEM-18) prior to using as stimuli for FLS cultures.
Results: SF from these patients did not generally stimulate HEK
transfectants. However, the addition of SF (0.09–25%) in combination
with TLR-2 or TLR-4 ligands resulted in signiﬁcant augmentation (up to
100-fold) of cytokine production from both the HEK transfectants and
from primary FLS. Levels of sCD14, a co-receptor for both TLR-2 and
TLR-4, were measured in SFs from early OA patients and found at levels
comparable to advanced OA and Rheumatoid Arthritis. Treatment with
anti-CD14 abolished the ability of SF to augment IL-8 production by FLS
in response to LPS, and diminished Pam3CysK4 responses.
Conclusions: In vitro, SF augments the response of FLS to both TLR-2 and
-4 ligands. This effect appeared to be largely due to sCD14, particularly in
response to the TLR-4 ligand LPS. As synoviocytes are expected to be in
contact with SF in vivo, these results suggest that SF sCD14 in the setting
of OA and meniscal injury can sensitize FLS to respond to inﬂammatory
stimuli such as TLR ligands. We speculate that this priming of FLS
inﬂammatory responses may have relevance to symptomatic “ﬂares”
seen clinically in OA patients.
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SOLUBLE PROTEINS DERIVED FROM INFRAPATELLAR FAT PAD
ADIPOCYTES OF OSTEOARTHRITIS PATIENTS MODULATE CD4+ T
CELL CYTOKINE PRODUCTION
A. Ioan-Facsinay, J.C. Kwekkeboom, M. Kloppenburg, R.E. Toes. Leiden
Univ. Med. Ctr., Leiden, Netherlands
Purpose: As shown in previous studies, the infrapatellar fat pad (IFP)
of OA patients has an inﬂammatory phenotype and could contribute
to the biological processes in the OA knee joint. We have previously
characterized the immune cell inﬁltrate in the IFP and have shown
the presence of CD4+ T cells. Because several studies have shown that
the phenotype of CD4+ T cells in adipose tissue is changing with the
Oral Presentations / Osteoarthritis and Cartilage 19S1 (2011) S7–S52 S19
adiposity of the individual, we hypothesized that this effect could be due
to the modulation of inﬁltrating T cells by the tissue-resident adipocytes.
Therefore, we investigated whether adipocytes from IFP can modulate
CD4+ T cell cytokine production.
Methods: CD4+ T cells were puriﬁed from peripheral blood mononuclear
cells isolated from buffycoats obtained from healthy volunteers. The
purity of the CD4+ T cells isolated using magnetic beads coated with
anti-human CD4 was above 95%. Plate-bound anti-CD3 and soluble anti-
CD28 antibodies were used to activate T cells. Adipocytes were isolated
from IFP of OA patients by collagenase digestion and were either cultured
with puriﬁed CD4+ T cells or were cultured in vitro for 24 hours in
DMEM/F12 medium supplemented with 0.5% bovine serum albumin
to generate adipocyte-conditioned medium (ACM). Cytokine production
was measured by intracellular cytokine staining (ICS), ELISA or cytokine
multiplex. Separation of the protein and lipid fractions was performed
using the Bligh and Dyer method, followed by precipitation of the protein
fraction and reconstitution in culture medium.
Results: CD4+ T cells produced increase levels of IFNg when activated
in the presence of adipocytes. This effect is mediated by soluble
mediators, as shown in transwell and ACM transfer experiments.
Moreover, separation of the protein and lipid fractions from the ACM
medium showed that soluble factors present in the protein fraction can
mediate this effect. Measurement of ten different cytokines known to
be secreted by T cells upon activation revealed that, besides IFNg, also
TNFa, IL-17 and IL-5 are modulated by IFP-derived ACM.
Conclusions: Soluble mediators secreted by IFP of OA patients can
modulate cytokine production of CD4+ T cells. Although the precise
mechanism involved in this modulation is still unknown, protein/lipid
fractionation studies indicated that molecules present in the protein
fraction can mediate this effect.
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TENASCIN-C LEVELS IN SYNOVIAL FLUID ARE ELEVATED AFTER
HUMAN JOINT INJURY AND CORRELATE WITH MARKERS OF MATRIX
DEGRADATION AND INFLAMMATION
P.S. Chockalingam1, W. Sun1, S. Lohmander2,3. 1Inﬂammation &
Remodelling, Pﬁzer, Cambridge, MA, USA; 2Lund Univ., Lund, Sweden; 3Univ.
of Southern Denmark, Odense, Denmark
Purpose: Tenascin-C (TNC) is a modular, multifunctional extracellular
matrix glycoprotein associated with the development of articular
cartilage that decreases during maturation of chondrocytes, and almost
disappears in adult cartilage. It is highly reexpressed in the cartilage and
synovium of diseased joints [1], and stimulates the production of pro-
inﬂammatory cytokines in human macrophages and synovial ﬁbroblasts
through activation of Toll-like receptor-4 (TLR4) [2]. We have shown
elevated levels of TNC in joint ﬂuid in animal models of joint disease [3],
and shown the capacity of TNC to induce inﬂammatory mediators and
matrix degradation in vitro in human joint cartilage [4]. The objective
of this study was to determine the release of TNC into synovial ﬂuid of
patients in joint disease and after joint injury, and to correlate levels of
TNC with markers of cartilage matrix degradation and inﬂammation in
the same ﬂuids.
Methods: Human knee synovial ﬂuids (n = 160) were obtained without
lavage from a cross-sectional convenience cohort. Diagnosis was
by arthroscopy, radiography, assessment of joint ﬂuid and clinical
examination. Diagnostic groups were knee healthy reference (REF
n=8), anterior cruciate ligament rupture, with or without concomitant
meniscus lesions (ACL n=56), isolated meniscus injury (MI n =69), acute
inﬂammatory arthritis (AIA n=16) and osteoarthritis (OA n=11). TNC
was measured using TNC Large ELISA (IBL®), with anti-TN-C 19C4MS mab
against the FNIII-C domain for capture, and HRP conjugated anti-TN-C
4F10TT mouse mab against the EGF domain for detection. ARG-aggrecan,
MMP1 and MMP3 ELISAs were performed as described [5,6].
Results: TNC in synovial ﬂuids varied widely between 44 and 2430ng/ml
(Table). Signiﬁcantly higher levels of TNC compared to REF subjects were
observed in all disease groups: 7, 5, 10, and 4-fold higher in ACL, MI, AIA,
and OA, respectively. TNC levels of ACL and MI patients decreased over
time following joint injury. Synovial ﬂuid levels of TNC were signiﬁcantly
correlated with aggrecanase-dependent ARG-aggrecan fragment release
(r = 0.46) and MMP1 (r = 0.51) and MMP3 protein (r = 0.46).
Conclusions: We show strongly elevated levels of TNC in human knee
joints immediately after injury or onset of disease, associated with
markers of inﬂammation and matrix degradation. Due to the complex
function of TNC we can only speculate on the consequences of the
increased TNC release into joint ﬂuid on cartilage matrix function and
disease development. TNC has a role in the assembly of the chondrocyte
matrix and as a soluble mediator of chondrocytes; deﬁciency of TNC
delays articular cartilage repair in mice [7]. The induction by TNC of TLR4,
inﬂammatory pathways, and matrix degradation in articular cartilage is
consistent with the correlation observed in the current study between
TNC levels and ARG-aggrecan fragments, MMP1, and MMP3 in human
synovial ﬂuids. TNC may serve as a marker of joint tissue injury.
ACL MI
Study Group 0–12w 12–52w >52w 0–12w 12–52w >52w AIA OA REF
Mean
sampling
time w
(range)
1 (0–6) 25 (13–48) 279
(57–1115)
3 (0–12) 24 (13–40) 418
(52–1926)
32 (0–510) 189
(0–481)
-
N 26 8 22 27 22 20 16 11 8
Mean age
(range)
25 (14–50) 31 (17–50) 31 (14–53) 34
(18–59)
35 (16–55) 45
(28–70)
68 (30–91) 67
(39–86)
28
(17–42)
Mean
OA grade
(range)
1 (1–3) 2 (1–3) 3 (1–6) 2 (0–5) 2 (0–3) 3 (1–8) 3 (0–9) 8 (3–9) 1 (0–1)
% male 62 63 68 93 86 70 63 45 75
Mean TCN
(ng/ml)
(range)
631
(196–1888)
533
(215–1032)
339
(101–1405)
405
(96–903)
327
(47–1062)
284
(12–1170)
939
(196–2430)
354
(107–817)
91
(44–218)
TNC 95% CI 459, 803 327, 739 212, 466 323, 487 207, 447 165, 402 587, 1290 236, 472 50, 132
Mean fold
/REF
6.9 5.9 3.7 4.5 3.6 3.1 10.3 3.9 -
p-value 0.0009 0.0005 0.0156 0.0001 0.0152 0.0298 0.0016 0.0011 -
Reference(s)
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“ALARMINS” S100A8 AND A9 ARE EXPRESSED IN THE SYNOVIUM
OF EARLY OA PATIENTS AND ARE INVOLVED IN DRIVING SYNOVIAL
ACTIVATION AND JOINT DESTRUCTION DURING EXPERIMENTAL
OSTEOARTHRITIS
P. van Lent. Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands
Purpose: “alarmins” S100 A8 and A9 are prominent proteins released
by activated phagocytes Evidence is accumulating that synovial tissue
activation contributes to OA cartilage pathology The aim was to evaluate
the presence of S100A8/S100A9 in synovia of patients with early OA
and to explore active involvement of S100A8/A9 in cartilage destruction
in experimental osteoarthritis models that differ in degree of synovial
activation.
Methods: Arthroscopic biopsies were taken from 30 early OA patients.
mRNA levels (RT-PCR) and immunolocalisation was determined and
related to joint destruction (Kellgren Lawrence score). Experimental OA
was either induced by transsection of the medial anterior meniscotibial
ligament which leads to destabilisation of the medial meniscus (DMM)
or by injection of collagenase into murine knee joints, which causes
overall ligament damage and broad instability. Collagenase-induced-
osteoarthritis involves chronic synovial activation in contrast to DMM.
Synovial expression of S100A8 and S100A9 was measured using
immunolocalisation. Both models were induced in S100A9−/− deﬁcient
mice (myeloid cells also lack S100A8 at the protein level). Primary
chondrocytes were stimulated with S100A8 and A9 and MMP levels
were measured using RT-PCR.
Results: mRNA and protein levels of S100A8 and A9 were signiﬁcantly
higher in synovial biopsies of early OA patients when compared to control
joints. S100 was predominantly found in synovial macrophages. Of great
interest, high levels correlated to increased joint destruction (KL score).
The function of S100A8 and S100A9 was further studied in experimental
OA models. Kinetic studies show that in surgically induced DMM model,
S100A8 and A9 was marginally expressed within the synovium, only
evident at day 7 after induction and consistent with limited synovial
thickening. The degree of OA cartilage pathology was similar in S100A9−/−
and WT mice at day 42 after induction of DMM.
In contrast, during the course of collagenase-induced osteoarthritis,
S100A8 and S100A9 was strongly upregulated in synovium at day 7
and remained high at days 14, 28 and 42. Expression of these proteins
